Skip to main content

Moderna shares plummet after Covid vaccine maker lowers 2022 sales outlook

Moderna also missed revenue and earnings expectations for the quarter.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.